Neutropenia Occurs More Often Under Carbimazole than Under Methimazole Treatment in Pediatric Graves’ Disease Patients
Thyroid® · 2024
DOI: 10.1089/thy.2023.0673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thyroid®, 2024. Verfasst von Vera Schempp und 7 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Pediatric Endocrinology, University Children's Hospitals, Bonn, Germany. Hauptthemen laut MEDLINE: Methimazole, Neutropenia, Antithyroid Agents, Graves Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Agranulocytosis is a rare antithyroid drug treatment (ATD) side effect seen in children suffering from Graves’ disease (GD). Neutropenia is a recognized adverse event associated with ATD but has also been reported as pre-treatment neutropenia in GD.
Methods
We performed a retrospective cohort study to analyze the longitudinal clinical and biochemical data of 161 pediatric patients with GD who received either methimazole (MMI) or carbimazole (CBZ) as ATD. The inclusion criteria were elevated free thyroxine (fT4 >25 pmol/L), suppressed thyrotropin (TSH 2.5 IU/L). Absolute neutrophil count (ANC) was used to define neutropenia (ANC
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Divisions of Pediatric Endocrinology, University Children's Hospitals, Bonn, Germany.
- Divisions of Pediatric Endocrinology, University Children's Hospitals, Erlangen, Germany.
- Divisions of Pediatric Endocrinology, University Children's Hospitals, Duesseldorf, Germany.
- D-MATH, ETH Zurich, Zurich, Switzerland.
Zitieren
APA
Schempp, V., Cebeci, A. N., Reinauer, C., Woelfle, J., Dörr, H. G., Roosen, M. T., Gohlke, J., & Gohlke, B. (2024). Neutropenia Occurs More Often Under Carbimazole than Under Methimazole Treatment in Pediatric Graves’ Disease Patients. Thyroid®. https://doi.org/10.1089/thy.2023.0673
Vancouver
Schempp V, Cebeci AN, Reinauer C, Woelfle J, Dörr HG, Roosen MT, et al. Neutropenia Occurs More Often Under Carbimazole than Under Methimazole Treatment in Pediatric Graves’ Disease Patients. Thyroid®. 2024. doi:10.1089/thy.2023.0673
BibTeX
@article{Schempp2024,
author = {Schempp, Vera and Cebeci, Ayse Nurcan and Reinauer, Christina and Woelfle, Joachim and Dörr, Helmuth-Günther and Roosen, Marie-Thérèse and Gohlke, Jonas and Gohlke, Bettina},
title = {Neutropenia Occurs More Often Under Carbimazole than Under Methimazole Treatment in Pediatric Graves’ Disease Patients},
journal = {Thyroid®},
year = {2024},
doi = {10.1089/thy.2023.0673}
}
EUVIMED